Latest Prescription Drugs news
FDA Approves First-in-Class Treatment for Myasthenia Gravis
posted December 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Biogen Cuts Price of Controversial Aduhelm in Half
posted December 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
First Long-Acting Injectable Approved for HIV PrEP
posted December 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Opioid Rx Up, Non-Rx Therapy Down During the Pandemic
posted December 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Withdrawal From Medetomidine Increasingly Seen in ICUs 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria Monthly Specialist Briefings
Stay Connected
